We provide you with 20 years of free, institutional-grade data for CPRX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of CPRX. Explore the full financial landscape of CPRX stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$4,944,041
Name | Action | Shares | Avg Price | Amount | Reported Date |
---|---|---|---|---|---|
Elsbernd Brian | Sale | -30,000 | $20.3 | $609,000 | 2025-09-10 |
Elsbernd Brian | Derivatives Exercise | 0 | 2025-09-10 | ||
Elsbernd Brian | Sale | -50,000 | $20.08 | $1,004,000 | 2025-09-05 |
Elsbernd Brian | Derivatives Exercise | 0 | 2025-09-05 | ||
Daly Richard J | Sale | -22,970 | $20.62 | $473,641 | 2025-08-28 |
Daly Richard J | Derivatives Exercise | 0 | 2025-08-28 | ||
Tierney David S | Sale | -26,000 | $20.2 | $525,200 | 2025-08-28 |
Tierney David S | Derivatives Exercise | 0 | 2025-08-28 | ||
Miller Steve | Sale | -115,000 | $20.28 | $2,332,200 | 2025-08-28 |
Miller Steve | Derivatives Exercise | 0 | 2025-08-28 | ||
Sundaram Preethi | Sale | -3,924 | $26.41 | $103,633 | 2025-06-12 |
MCENANY PATRICK J | Sale | -200,000 | $25.95 | $5,189,000 | 2025-06-10 |
Daly Richard J | Sale | 70,000 | $24.86 | 2025-06-03 | |
INGENITO GARY | Sale | -244,000 | $23.68 | $5,777,920 | 2025-05-15 |
INGENITO GARY | Derivatives Exercise | 0 | 2025-05-15 | ||
INGENITO GARY | Sale | -225,000 | $22.09 | $4,970,250 | 2025-03-07 |
INGENITO GARY | Derivatives Exercise | 0 | 2025-03-07 | ||
Elsbernd Brian | Sale | -62,975 | $23.23 | $1,462,909 | 2025-03-05 |
Elsbernd Brian | Derivatives Exercise | 0 | 2025-03-05 | ||
Del Carmen Jeffrey | Sale | -30,423 | $22.89 | $696,382 | 2025-03-05 |
Harper Molly | Derivatives Exercise | 4,000 | 2025-02-19 | ||
INGENITO GARY | Sale | -2,435 | 2025-02-19 | ||
INGENITO GARY | Derivatives Exercise | 10,000 | 2025-02-19 | ||
Del Carmen Jeffrey | Sale | -3,125 | 2025-02-19 | ||
Del Carmen Jeffrey | Derivatives Exercise | 10,667 | 2025-02-19 | ||
O'Keeffe Charles B | Derivatives Exercise | 4,000 | 2025-02-19 | ||
Elsbernd Brian | Sale | -2,353 | 2025-02-19 | ||
Elsbernd Brian | Derivatives Exercise | 9,667 | 2025-02-19 | ||
Sundaram Preethi | Sale | -5,965 | 2025-02-19 | ||
Sundaram Preethi | Derivatives Exercise | 16,667 | 2025-02-19 | ||
DENKHAUS DONALD A | Derivatives Exercise | 4,000 | 2025-02-19 | ||
Daly Richard J | Sale | -1,574 | 2025-02-19 | ||
Daly Richard J | Derivatives Exercise | 4,000 | 2025-02-19 | ||
Tierney David S | Derivatives Exercise | 4,000 | 2025-02-19 | ||
Miller Steve | Derivatives Exercise | 13,667 | 2025-02-19 | ||
DENKHAUS DONALD A | Derivatives Exercise | 0 | 2025-01-10 | ||
Kalb Michael Wayne | Sale | -2,941 | 2025-01-03 | ||
Kalb Michael Wayne | Derivatives Exercise | 7,138 | 2025-01-03 | ||
Daly Richard J | Sale | -10,600 | 2025-01-03 | ||
Daly Richard J | Derivatives Exercise | 42,105 | 2025-01-03 | ||
INGENITO GARY | Sale | -3,541 | 2024-12-31 | ||
INGENITO GARY | Derivatives Exercise | 9,000 | 2024-12-31 | ||
Tierney David S | Derivatives Exercise | 1,333 | 2024-12-31 | ||
Elsbernd Brian | Sale | -1,941 | 2024-12-31 | ||
Elsbernd Brian | Derivatives Exercise | 6,667 | 2024-12-31 | ||
Daly Richard J | Sale | -324 | 2024-12-31 | ||
Daly Richard J | Derivatives Exercise | 1,333 | 2024-12-31 | ||
DENKHAUS DONALD A | Derivatives Exercise | 1,333 | 2024-12-31 | ||
Del Carmen Jeffrey | Sale | -3,839 | 2024-12-31 | ||
Del Carmen Jeffrey | Derivatives Exercise | 8,667 | 2024-12-31 | ||
Harper Molly | Derivatives Exercise | 1,333 | 2024-12-31 | ||
Sundaram Preethi | Sale | -2,345 | 2024-12-31 | ||
Sundaram Preethi | Derivatives Exercise | 6,667 | 2024-12-31 | ||
O'Keeffe Charles B | Derivatives Exercise | 1,333 | 2024-12-31 | ||
Miller Steve | Derivatives Exercise | 14,000 | 2024-12-31 | ||
Miller Steve | Derivatives Exercise | 0 | 2024-12-17 | ||
Elsbernd Brian | Sale | -1,720 | 2024-12-11 | ||
Elsbernd Brian | Derivatives Exercise | 7,067 | 2024-12-11 | ||
MCENANY PATRICK J | Derivatives Exercise | 3,533 | 2024-12-11 | ||
DENKHAUS DONALD A | Derivatives Exercise | 1,413 | 2024-12-11 | ||
Harper Molly | Derivatives Exercise | 1,413 | 2024-12-11 | ||
O'Keeffe Charles B | Derivatives Exercise | 1,413 | 2024-12-11 | ||
Del Carmen Jeffrey | Sale | -2,355 | 2024-12-11 | ||
Del Carmen Jeffrey | Derivatives Exercise | 8,039 | 2024-12-11 | ||
Sundaram Preethi | Sale | -2,415 | 2024-12-11 | ||
Sundaram Preethi | Derivatives Exercise | 6,855 | 2024-12-11 | ||
Thompson Tamar | Derivatives Exercise | 1,413 | 2024-12-11 | ||
Tierney David S | Derivatives Exercise | 1,413 | 2024-12-11 | ||
Miller Steve | Sale | -50,000 | $21.93 | $1,096,350 | 2024-12-11 |
Miller Steve | Derivatives Exercise | 11,872 | 2024-12-11 | ||
INGENITO GARY | Sale | -2,891 | 2024-12-11 | ||
INGENITO GARY | Derivatives Exercise | 7,349 | 2024-12-11 | ||
Harper Molly | Sale | -17,500 | $22 | $385,000 | 2024-11-29 |
Harper Molly | Derivatives Exercise | 0 | 2024-11-29 | ||
Elsbernd Brian | Sale | -13,256 | $21.65 | $286,992 | 2024-11-29 |
Elsbernd Brian | Derivatives Exercise | 0 | 2024-11-29 | ||
INGENITO GARY | Sale | -12,000 | $22.74 | $272,880 | 2024-11-29 |
INGENITO GARY | Derivatives Exercise | 0 | 2024-11-29 | ||
Sundaram Preethi | Grant, award...etc | 154,362 | 2024-11-25 | ||
Miller Steve | Grant, award...etc | 202,958 | 2024-11-25 | ||
MCENANY PATRICK J | Grant, award...etc | 43,591 | 2024-11-25 | ||
DENKHAUS DONALD A | Grant, award...etc | 23,248 | 2024-11-25 | ||
Tierney David S | Grant, award...etc | 23,248 | 2024-11-25 | ||
O'Keeffe Charles B | Grant, award...etc | 23,248 | 2024-11-25 | ||
INGENITO GARY | Grant, award...etc | 125,696 | 2024-11-25 | ||
Kalb Michael Wayne | Grant, award...etc | 169,248 | 2024-11-25 | ||
Harper Molly | Grant, award...etc | 23,248 | 2024-11-25 | ||
Daly Richard J | Grant, award...etc | 491,160 | 2024-11-25 | ||
Elsbernd Brian | Grant, award...etc | 126,704 | 2024-11-25 | ||
Thompson Tamar | Grant, award...etc | 23,248 | 2024-11-25 | ||
Del Carmen Jeffrey | Grant, award...etc | -137,553 | 2024-11-25 | ||
INGENITO GARY | Sale | -38,000 | $21.2 | $805,562 | 2024-11-22 |
INGENITO GARY | Derivatives Exercise | 0 | 2024-11-22 | ||
MCENANY PATRICK J | Sale | -170,845 | $21.19 | $3,619,864 | 2024-11-21 |
MCENANY PATRICK J | Derivatives Exercise | 0 | 2024-11-21 | ||
MCENANY PATRICK J | Sale | -137,155 | $22.98 | $3,151,548 | 2024-11-15 |
MCENANY PATRICK J | Derivatives Exercise | 0 | 2024-11-15 | ||
MCENANY PATRICK J | Sale | -492,000 | $23.55 | $11,585,616 | 2024-11-13 |
MCENANY PATRICK J | Derivatives Exercise | 0 | 2024-11-13 | ||
Tierney David S | Sale | -15,000 | $20.1 | $301,455 | 2024-08-23 |
Tierney David S | Derivatives Exercise | 30,000 | 2024-08-23 | ||
Miller Steve | Sale | -150,000 | $20.26 | $3,039,150 | 2024-08-22 |
Del Carmen Jeffrey | Sale | -36,058 | $18.44 | $664,910 | 2024-08-13 |
Del Carmen Jeffrey | Derivatives Exercise | 0 | 2024-08-13 | ||
INGENITO GARY | Sale | -100,000 | $18.04 | $1,804,000 | 2024-08-13 |
INGENITO GARY | Derivatives Exercise | 0 | 2024-08-13 | ||
Del Carmen Jeffrey | Sale | -7,541 | $16.07 | $121,184 | 2024-06-11 |
INGENITO GARY | Sale | -80,000 | $16.16 | $1,292,800 | 2024-06-07 |
INGENITO GARY | Derivatives Exercise | 0 | 2024-06-07 | ||
Harper Molly | Sale | -5,333 | $16.3 | $86,949 | 2024-06-05 |
Daly Richard J | Sale | -17,323 | $15.97 | $276,735 | 2024-06-05 |
Daly Richard J | Derivatives Exercise | 0 | 2024-06-05 | ||
Tierney David S | Sale | -25,000 | $15.68 | $392,000 | 2024-04-10 |
Tierney David S | Derivatives Exercise | 50,000 | 2024-04-10 | ||
Elsbernd Brian | Sale | -25,000 | $16.44 | $411,000 | 2024-03-28 |
Tierney David S | Derivatives Exercise | 4,000 | 2024-02-16 | ||
Harper Molly | Derivatives Exercise | 4,000 | 2024-02-16 | ||
Miller Steve | Derivatives Exercise | 13,667 | 2024-02-16 | ||
O'Keeffe Charles B | Derivatives Exercise | 4,000 | 2024-02-16 | ||
Sundaram Preethi | Sale | -6,025 | 2024-02-16 | ||
Sundaram Preethi | Derivatives Exercise | 16,667 | 2024-02-16 | ||
INGENITO GARY | Sale | -2,435 | 2024-02-16 | ||
INGENITO GARY | Derivatives Exercise | 10,000 | 2024-02-16 | ||
Elsbernd Brian | Sale | -2,353 | 2024-02-16 | ||
Elsbernd Brian | Derivatives Exercise | 9,667 | 2024-02-16 | ||
Del Carmen Jeffrey | Sale | -3,125 | 2024-02-16 | ||
Del Carmen Jeffrey | Derivatives Exercise | 10,667 | 2024-02-16 | ||
DENKHAUS DONALD A | Derivatives Exercise | 4,000 | 2024-02-16 | ||
Daly Richard J | Sale | -1,186 | 2024-02-16 | ||
Daly Richard J | Derivatives Exercise | 4,000 | 2024-02-16 | ||
DENKHAUS DONALD A | Derivatives Exercise | 0 | 2024-02-06 | ||
MCENANY PATRICK J | Derivatives Exercise | 143,000 | 2024-01-31 | ||
Tierney David S | Derivatives Exercise | 0 | 2024-01-03 | ||
O'Keeffe Charles B | Derivatives Exercise | 0 | 2024-01-03 | ||
Daly Richard J | Grant, award...etc | 1,365,319 | 2024-01-03 | ||
MCENANY PATRICK J | Derivatives Exercise | 0 | 2024-01-03 | ||
DENKHAUS DONALD A | Derivatives Exercise | 1,333 | 2023-12-29 |
The information provided in this report about CPRX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Catalyst Pharmaceuticals, Inc(NASDAQ:CPRX)Â


Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, a proprietary form of amifampridine phosphat...
Website: http://www.catalystpharma.com
Founded: 2002
Full Time Employees: 76
Sector: Healthcare
Industry: Biotechnology